Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01029509 |
|
Recruitment Status :
Terminated
(Colloborator-Sponsor decision to terminate.)
First Posted : December 10, 2009
Last Update Posted : July 23, 2012
|
Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | August 2011 |
| Actual Study Completion Date : | August 2011 |